Michael Gribble

Discovery of AMG 232, a Potent, Selective, and Orally Bioavailable MDM2–p53 Inhibitor in Clinical Development

Daqing Sun, Zhihong Li, Yosup Rew et al. · Journal of Medicinal Chemistry · 2014 · 290 citations · Full text

Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer

Razvan Galalae, Alvaro A. Martinez, Tim Mate et al. · International Journal of Radiation Oncology*Biology*Physics · 2004 · 223 citations

Urology, Genitourinary Cancer, Medicine +7

High dose-rate afterloading 192iridium prostate brachytherapy: feasibility report

Timothy P. Mate, James E. Gottesman, John F. Hatton et al. · International Journal of Radiation Oncology*Biology*Physics · 1998 · 220 citations

Radiation Medicine, Radiobiology, Prostate Brachytherapy +6

Asymmetric Copper Hydride-Catalyzed Markovnikov Hydrosilylation of Vinylarenes and Vinyl Heterocycles

Michael Gribble, Michael T. Pirnot, Jeffrey S. Bandar et al. · Journal of the American Chemical Society · 2017 · 176 citations · Full text

Chemical Engineering, Vinyl Heterocycles, Engineering +13

Asymmetric Cu-Catalyzed 1,4-Dearomatization of Pyridines and Pyridazines without Preactivation of the Heterocycle or Nucleophile

Michael Gribble, Sheng Guo, Stephen L. Buchwald · Journal of the American Chemical Society · 2018 · 169 citations · Full text

Asymmetric Cu-catalyzed 1,4-Dearomatization, Room Temperature, Chemical Engineering +12